Bluschke, Annet
Schuster, Jacqueline
Roessner, Veit
Beste, Christian
Article History
Received: 29 September 2017
Accepted: 19 January 2018
First Online: 1 February 2018
Competing Interests
: A.B. and J.S. declare no competing or potential conflicts of interest. V.R. has received payment for consulting and writing activities from Lilly, Novartis, and Shire Pharmaceuticals, lecture honoraria from Lilly, Novartis, Shire Pharmaceuticals, and Medice Pharma, and support for research from Shire and Novartis. He has carried out (and is currently carrying out) clinical trials in cooperation with the Novartis, Shire, and Otsuka companies. C.B. has received payment for consulting and/or is carrying out studies for GlaxoSmithKline, Teva, Genzyme, Biogen and Novartis.